# Question 54

**Type:** Genomic Alteration Frequencies

**Question:** Which KRAS mutations are most common in colorectal cancer?

**Answer:**

I'll help you find the most common KRAS mutations in colorectal cancer. Let me start by finding the appropriate colorectal cancer study and then navigate to the KRAS mutation data.



Calling `resolve_and_route` with args:
```json
{
  "targetPage": "results",
  "studyKeywords": [
    "colorectal",
    "TCGA"
  ]
}
```



Result from `resolve_and_route`:
```json
{"success":true,"message":"Found 3 matching studies. Review the user's original query to determine if it clearly matches one study. If yes, use that study's metadata to call navigate_to_resultsview. If ambiguous, ask the user to choose.","data":{"recommendedTool":"navigate_to_resultsview","needsStudySelection":true,"totalCount":3,"resolvedStudyIds":["coadread_tcga","coadread_tcga_pub","coadread_tcga_pan_can_atlas_2018"],"studiesWithMetadata":[{"studyId":"coadread_tcga","name":"Colorectal Adenocarcinoma (TCGA, Firehose Legacy)","sampleCount":1036,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=coadread_tcga","metadata":{"clinicalAttributeIds":["AGE","AJCC_METASTASIS_PATHOLOGIC_PM","AJCC_NODES_PATHOLOGIC_PN","AJCC_PATHOLOGIC_TUMOR_STAGE","AJCC_STAGING_EDITION","AJCC_TUMOR_PATHOLOGIC_PT","BRAF_GENE_ANALYSIS_INDICATOR","BRAF_GENE_ANALYSIS_RESULT","CANCER_TYPE","CANCER_TYPE_DETAILED","CLINICAL_STAGE","CLIN_M_STAGE","CLIN_N_STAGE","CLIN_T_STAGE","DAYS_TO_COLLECTION","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","DAYS_TO_PATIENT_PROGRESSION_FREE","DAYS_TO_SPECIMEN_COLLECTION","DAYS_TO_TUMOR_PROGRESSION","DFS_MONTHS","DFS_STATUS","DISEASE_CODE","ETHNICITY","EXTRANODAL_INVOLVEMENT","FORM_COMPLETION_DATE","FRACTION_GENOME_ALTERED","HEIGHT","HISTOLOGICAL_DIAGNOSIS","HISTORY_NEOADJUVANT_TRTYN","HISTORY_OTHER_MALIGNANCY","ICD_10","ICD_O_3_HISTOLOGY","ICD_O_3_SITE","INFORMED_CONSENT_VERIFIED","INITIAL_PATHOLOGIC_DIAGNOSIS_METHOD","INITIAL_PATHOLOGIC_DX_YEAR","IS_FFPE","KRAS_GENE_ANALYSIS_INDICATOR","KRAS_MUTATION","LONGEST_DIMENSION","LYMPHOVASCULAR_INVASION_INDICATOR","LYMPH_NODES_EXAMINED","LYMPH_NODES_EXAMINED_HE_COUNT","LYMPH_NODES_EXAMINED_IHC_COUNT","LYMPH_NODE_EXAMINED_COUNT","METHOD_OF_SAMPLE_PROCUREMENT","MUTATION_COUNT","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","OCT_EMBEDDED","ONCOTREE_CODE","OS_MONTHS","OS_STATUS","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","OTHER_PATIENT_ID","OTHER_SAMPLE_ID","PATHOLOGY_REPORT_FILE_NAME","PATHOLOGY_REPORT_UUID","PERINEURAL_INVASION","PHARMACEUTICAL_TX_ADJUVANT","PRIMARY_SITE_PATIENT","PROJECT_CODE","PROSPECTIVE_COLLECTION","RACE","RADIATION_TREATMENT_ADJUVANT","RESIDUAL_TUMOR","RETROSPECTIVE_COLLECTION","SAMPLE_COUNT","SAMPLE_INITIAL_WEIGHT","SAMPLE_TYPE","SAMPLE_TYPE_ID","SEX","SHORTEST_DIMENSION","SITE_OF_TUMOR_TISSUE","SOMATIC_STATUS","SPECIMEN_CURRENT_WEIGHT","SPECIMEN_FREEZING_METHOD","SPECIMEN_SECOND_LONGEST_DIMENSION","STAGE_OTHER","TIME_BETWEEN_CLAMPING_AND_FREEZING","TIME_BETWEEN_EXCISION_AND_FREEZING","TISSUE_SOURCE_SITE","TMB_NONSYNONYMOUS","TREATMENT_OUTCOME_FIRST_COURSE","TUMOR_STATUS","VASCULAR_INVASION_INDICATOR","VIAL_NUMBER","WEIGHT"],"molecularProfileIds":["coadread_tcga_gistic","coadread_tcga_linear_CNA","coadread_tcga_methylation_hm450","coadread_tcga_mrna","coadread_tcga_mrna_median_Zscores","coadread_tcga_mrna_median_all_sample_Zscores","coadread_tcga_mutations","coadread_tcga_protein_quantification","coadread_tcga_protein_quantification_zscores","coadread_tcga_rna_seq_v2_mrna","coadread_tcga_rna_seq_v2_mrna_median_Zscores","coadread_tcga_rna_seq_v2_mrna_median_all_sample_Zscores","coadread_tcga_rppa","coadread_tcga_rppa_Zscores"]}},{"studyId":"coadread_tcga_pub","name":"Colorectal Adenocarcinoma (TCGA, Nature 2012)","sampleCount":736,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=coadread_tcga_pub","metadata":{"clinicalAttributeIds":["CANCER_TYPE","CANCER_TYPE_DETAILED","COPY_NUMBER","EXPRESSION_SUBTYPE","FRACTION_GENOME_ALTERED","HISTOLOGICAL_SUBTYPE","HYPERMUTATED","ICLUSTER","METHYLATION_STATUS","METHYLATION_SUBTYPE","MLH1_SILENCING","MRNA_DATA","MSI_STATUS","MUTATION_COUNT","ONCOTREE_CODE","OS_MONTHS","OS_STATUS","PRIMARY_SITE","PRIMARY_TUMOR_PATHOLOGIC_SPREAD","SAMPLE_COUNT","SAMPLE_TYPE","SEQUENCED","SEX","SOMATIC_STATUS","TMB_NONSYNONYMOUS","TUMOR_STAGE_2009"],"molecularProfileIds":["coadread_tcga_pub_gistic","coadread_tcga_pub_linear_CNA","coadread_tcga_pub_methylation_hm27","coadread_tcga_pub_mirna","coadread_tcga_pub_mirna_median_Zscores","coadread_tcga_pub_mrna","coadread_tcga_pub_mrna_median_Zscores","coadread_tcga_pub_mrna_median_all_sample_Zscores","coadread_tcga_pub_mrna_merged_median_Zscores","coadread_tcga_pub_mutations","coadread_tcga_pub_rna_seq_mrna","coadread_tcga_pub_rna_seq_mrna_median_Zscores","coadread_tcga_pub_rna_seq_mrna_median_all_sample_Zscores"]}},{"studyId":"coadread_tcga_pan_can_atlas_2018","name":"Colorectal Adenocarcinoma (TCGA, PanCancer Atlas)","sampleCount":594,"studyViewUrl":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/study?id=coadread_tcga_pan_can_atlas_2018","metadata":{"clinicalAttributeIds":["AGE","AJCC_PATHOLOGIC_TUMOR_STAGE","AJCC_STAGING_EDITION","ANEUPLOIDY_SCORE","BUFFA_HYPOXIA_SCORE","CANCER_TYPE","CANCER_TYPE_ACRONYM","CANCER_TYPE_DETAILED","DAYS_LAST_FOLLOWUP","DAYS_TO_BIRTH","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","DFS_MONTHS","DFS_STATUS","DSS_MONTHS","DSS_STATUS","ETHNICITY","FORM_COMPLETION_DATE","FRACTION_GENOME_ALTERED","GENETIC_ANCESTRY_LABEL","GRADE","HISTORY_NEOADJUVANT_TRTYN","ICD_10","ICD_O_3_HISTOLOGY","ICD_O_3_SITE","INFORMED_CONSENT_VERIFIED","IN_PANCANPATHWAYS_FREEZE","MSI_SCORE_MANTIS","MSI_SENSOR_SCORE","MUTATION_COUNT","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","ONCOTREE_CODE","OS_MONTHS","OS_STATUS","OTHER_PATIENT_ID","PATH_M_STAGE","PATH_N_STAGE","PATH_T_STAGE","PERSON_NEOPLASM_CANCER_STATUS","PFS_MONTHS","PFS_STATUS","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","PRIOR_DX","RACE","RADIATION_THERAPY","RAGNUM_HYPOXIA_SCORE","SAMPLE_COUNT","SAMPLE_TYPE","SEX","SOMATIC_STATUS","SUBTYPE","TBL_SCORE","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","TISSUE_SOURCE_SITE","TISSUE_SOURCE_SITE_CODE","TMB_NONSYNONYMOUS","TUMOR_TISSUE_SITE","TUMOR_TYPE","WEIGHT","WINTER_HYPOXIA_SCORE"],"molecularProfileIds":["coadread_tcga_pan_can_atlas_2018_armlevel_cna","coadread_tcga_pan_can_atlas_2018_genetic_ancestry","coadread_tcga_pan_can_atlas_2018_gistic","coadread_tcga_pan_can_atlas_2018_log2CNA","coadread_tcga_pan_can_atlas_2018_methylation_hm27_hm450_merge","coadread_tcga_pan_can_atlas_2018_mutations","coadread_tcga_pan_can_atlas_2018_protein_quantification","coadread_tcga_pan_can_atlas_2018_protein_quantification_zscores","coadread_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","coadread_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","coadread_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_all_sample_Zscores","coadread_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_all_sample_ref_normal_Zscores","coadread_tcga_pan_can_atlas_2018_rppa","coadread_tcga_pan_can_atlas_2018_rppa_Zscores","coadread_tcga_pan_can_atlas_2018_structural_variants"]}}]}}
```


Perfect! I found three colorectal cancer studies. I'll use the **PanCancer Atlas** version as it's the most comprehensive and up-to-date. Let me generate the direct link to view KRAS mutations in colorectal cancer.



Calling `navigate_to_resultsview_page` with args:
```json
{
  "studyIds": [
    "coadread_tcga_pan_can_atlas_2018"
  ],
  "genes": [
    "KRAS"
  ],
  "tab": "mutations"
}
```



Result from `navigate_to_resultsview_page`:
```json
{"success":true,"message":"Navigating to https://deploy-preview-5312--cbioportalfrontend.netlify.app/results/mutations?cancer_study_list=coadread_tcga_pan_can_atlas_2018&gene_list=KRAS&case_set_id=coadread_tcga_pan_can_atlas_2018_all","url":"https://deploy-preview-5312--cbioportalfrontend.netlify.app/results/mutations?cancer_study_list=coadread_tcga_pan_can_atlas_2018&gene_list=KRAS&case_set_id=coadread_tcga_pan_can_atlas_2018_all","data":{"studyIds":["coadread_tcga_pan_can_atlas_2018"],"studies":[{"studyId":"coadread_tcga_pan_can_atlas_2018","name":"Colorectal Adenocarcinoma (TCGA, PanCancer Atlas)","sampleCount":594}],"genes":["KRAS"],"caseSetId":"coadread_tcga_pan_can_atlas_2018_all","molecularProfiles":["coadread_tcga_pan_can_atlas_2018_mutations"]}}
```


Here is the direct link to view KRAS mutations in colorectal cancer:

**https://deploy-preview-5312--cbioportalfrontend.netlify.app/results/mutations?cancer_study_list=coadread_tcga_pan_can_atlas_2018&gene_list=KRAS&case_set_id=coadread_tcga_pan_can_atlas_2018_all**

This link takes you to the **Mutations tab** for KRAS in the **Colorectal Adenocarcinoma (TCGA, PanCancer Atlas)** study with 594 samples.

On this page, you'll be able to see:

1. **Mutation frequency** - What percentage of colorectal cancer samples have KRAS mutations
2. **Specific mutation types** - The most common amino acid changes (e.g., G12D, G12V, G13D)
3. **Mutation diagram** - Visual representation showing where mutations occur in the KRAS protein
4. **Mutation table** - Detailed list of all mutations with their frequencies and functional impact

**Key findings you can expect:** KRAS is one of the most frequently mutated genes in colorectal cancer, with the most common hotspot mutations occurring at codons 12, 13, and 61 (particularly G12D, G12V, and G13D).

If you'd like to see the OncoPrint view instead or explore other colorectal cancer datasets, just let me know!

---

## Model Information
- **model**: us.anthropic.claude-sonnet-4-5-20250929-v1:0
- **temperature**: 0.0
- **max_output_tokens**: 1024
- **thinking_enabled**: False
- **thinking_budget_tokens**: 1024
- **response_time_seconds**: 14.643722858978435
- **agent_type**: mcp-navigator-agent

### Usage
- **input_tokens**: 69600
- **output_tokens**: 646
- **total_tokens**: 70246
- **cache_creation_input_tokens**: 0
- **cache_read_input_tokens**: 0

---

*Generated on 2026-02-05 01:50:55*